July 23, 2018
NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark  this link  for your convenience.

Some materials from our July NRG Oncology Semiannual Meeting have now been posted to the NRG Oncology website. Read more

The NRG Oncology publications page on the website has moved. Read more

PENDING ACTIVATION
GYNECOLOGIC
NRG-GY016: A Phase II Study of MK-3475 (Pembrolizumab)(NSC #776864) and Epacadostat (NSC #766086) in Recurrent Clear Cell Carcinoma of the Ovary. Watch for upcoming notice of activation date.

AMENDMENTS
GYNECOLOGIC
GOG-0225: Amendment 9; version date: July 17, 2018 (posted on NRG Oncology).

OTHER PROTOCOL NOTICES
1. BRAIN
NRG-BN001: Accrual for advanced imaging sites enrolling to the Photon Cohort (Group I) reached its target and closed. See Study Memo dated July 20, 2018 (posted to CTSU).

2. BREAST
NSABP B-55/BIG 6-13: Statistical/Progress Report (posted on NRG Oncology).

3. GYNECOLOGIC
NRG-GY007: Currently open to Phase II accrual.  Version Date: April 6, 2018 (posted on NRG Oncology).

NRG-GY009: Currently open to Phase II/III accrual.  Version Date: March 19, 2018 (posted on CTSU).

4. VTOC Training
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat.  The next webinar training is scheduled for August 15, 2018.


 

DRUG SAFETY UPDATES
Safety updates have been issued for the following studies: 

 

DRUG NAME

PROTOCOL

WEBSITE FOR SAFETY REPORTS

Atezolimumab

NRG-GY009

CTSU

Durvalumab

NRG-HN004

CTSU

Ipilimumab

NRG-BN002

NRG-GY003

NRG

NRG

Nivolumab

 

NRG-BN002

NRG-GY002

NRG-GY003

NRG

NRG

NRG

Olaparib

NSABP-B-55

CTSU

Pembrolizumab

NRG-HN003

NRG

Materials from the July NRG Oncology Semiannual Meeting

The recording of the NRG Oncology Digital Health and Personal Connected Health session is now available on our Meeting Resources webpage. You will also find slides for the Clinical Trials 101: New Investigator Educational Session and slides from the General Session which overviewed NRG Oncology’s current research and committee initiatives, the top accruing sites from January-June of 2018, and more.

New ASCO Campaign Aims to Spotlight Federally Funded Cancer

ASCO recently announced their new national outreach campaign, "I Live to Conquer Cancer."  This initiative is intended to bring awareness to the importance of federal funding for cancer research and to highlight individuals who dedicate their lives to finding new ways to diagnose, prevent, and treat cancer.  NRG Oncology is excited to participate in this new campaign and encourages our researchers to share why they #livetoconquercancer. Click here to find out how you can share your story and other resources to support this initiative.

NRG Oncology Breast Cancer Committee – Applications Deadline Extended

The deadline for submitting applications for the NRG Oncology Breast Cancer Committee has been extended through July 31, 2018. If you or someone at your site is interested in becoming a member of the Breast Cancer Committee OR if you are already a member and want to reapply, please complete the application (available on the NRG Oncology website) and submit it before the extended deadline, July 31, 2018. If you have any questions, please contact Toni Arthurs at ArthursT@NRGOncology.org

 

NEW LOCATION ON WEBSITE
Please note that the NRG Oncology Publications tab on the website has relocated. You can now find the publications section under the Clinical Trials tab of the website:  nrgoncology.org/Clinical-Trials/Publications 

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.


JOURNAL ARTICLES

Armer JM, Ballman KV, McCall L, Armer NC, Sun Y, Udmuangpia T, Hunt KK, Mittendorf EA, Byrd DR, Julian TB, Boughey JC. Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy. Support Care Cancer. 2018 Jul 6. doi: 10.1007/s00520-018-4334-7. [Epub ahead of print] PubMed PMID: 29980907.   Read more

PUBLICATIONS REMINDERS
Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings

American Association of Physicists in Medicine (AAPM); Jul 29 - Aug 2, 2018; Nashville, TN

ASCO Research Community Forum Annual Meeting; Sep 23-24, 2018; Washington, DC

College of American Pathologists (CAP); Oct 20-24, 2018, Chicago, IL

European Society for Medical Oncology (ESMO); Oct 19-23, 2018; Munich, Germany

Society of Clinical Research (SOCRA); Sep 28-30, 2018; New Orleans, LA

Upcoming Abstract Submission Deadlines

American Society of Clinical Oncology (ASCO) GI; Jan 17-19, 2019; San Francisco, CA; due to publications committee Sep 12, 2018; meeting abstracts submission deadline Sep 26, 2018

American Society of Clinical Oncology (ASCO) GU; Feb 14-16, 2019; San Francisco, CA; due to publications committee Oct 9, 2018; meeting abstracts submission deadline Oct 23, 2018

American Society for Radiation Oncology (ASTRO); Oct 21-24, 2018; San Antonio, TX; Late-breaking submission site closes Aug 1, 2018

European Society for Medical Oncology (ESMO); Oct 19-23, 2018;Munich, Germany; Late-breaking Sep 17, 2018

European Society for Radiotherapy and Oncology (ESTRO); Apr 26-30, 2019; Milan , Italy; due to publications committee Oct 8, 2018; meeting abstracts submission deadline Oct 22, 2018

NRG Oncology is proud to be an active participant of #CancerMoonShot.
View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse